Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06066918
NA
Prophylactic Pregabalin Treatment Following Spinal Cord Injury
Sponsor: Loewenstein Hospital
View on ClinicalTrials.gov
Summary
Patients arriving to rehabilitation up to 3 months following SCI will be given (study group) or not (control group) Lyrica (75X2). They will be followed for central pain development.
Official title: The Effect of Preventional Drug Therapy on Pain Regulation Mechanisms Among Spinal Cord Injury Patients Who Have Yet to Develop Central Pain
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2021-07-13
Completion Date
2026-02-05
Last Updated
2025-06-24
Healthy Volunteers
No
Conditions
Interventions
DRUG
Pregabalin 75mg
Pregabalin 75 mg twice a day
Locations (1)
Loewenstein Rehabilitation Hospital
Raanana, Israel